Clopidogrel Proton-Pump Inhibitors Study.

Trial Profile

Clopidogrel Proton-Pump Inhibitors Study.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 25 Oct 2016

At a glance

  • Drugs Clopidogrel; Omeprazole; Pantoprazole
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Oct 2016 Status changed from suspended to withdrawn prior to enrolment since the published data resolved the study goals we decided not to start it.
    • 23 Jun 2011 Planned end date changed from 1 Feb 2012 to 1 Dec 2013 as reported by
    • 23 Jun 2011 Status changed from not yet recruiting to suspended as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top